News from Demuris

Demuris secures almost €500,000 of EU grant funding

20 February 2009

Demuris has been awarded a significant amount of non-dilutive funding (€489,700) as a partner in the EU Framework Programme 7 project 'DIVINOCELL', which runs until 2013.

In a consortium of 11 partners, the challenge of DIVINOCELL is to develop new compounds to treat the infections caused by Gram-negative pathogens. Demuris' role in the project is to carry out systematic screening and hit identification – identifying and prioritising new targets and opportunities for productive screening assays.
Publications resulting from the project can be found on the DIVINOCELL website below.

DIVINOCELL Update | 01 April 2011

In its second year, the DIVINOCELL project has made good progress, which is demonstrated in the First Periodic Report, published on the DIVINOCELL website.


Demuris Limited
Newcastle Biomedicine Bio-Incubators,
Faculty of Medical Sciences, Framlington Place,
Newcastle upon Tyne, NE2 4HH, UK

Tel: +44 (0)191 223 5608
Fax: +44 (0)191 223 5609

Demuris Limited is registered in England, company number: 06255507

Demuris Limited 2015